13 Atopic Dermatitis Clinical Trials in Bakersfield, CA (2026)

Q: How do I join a clinical trial in Bakersfield?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Bakersfield research site will contact you.

Recruiting Atopic Dermatitis Studies in Bakersfield

NCT03486873Recruiting

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

The purpose of this study is to evaluate the long-term safety and efficacy of pembrolizumab (MK-3475) in participants from previous Merck pembrolizumab-based parent studies who transition into this ex...

Bakersfield, CAPHASE33,500 participantsMerck Sharp & Dohme LLC

View Study Details

NCT07290803Recruiting

This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

The objectives of this prospective non-interventional study are to characterize the existing unmet needs across the spectrum of atopic dermatitis (AD), enhance the understanding of the patient journey...

Bakersfield, CA1,000 participantsSanofi

View Study Details

NCT06510374Recruiting

Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

A phase 3b, Randomized, Controlled Trial of Nadofaragene Firadenovec vs. Observation in Participants with Intermediate Risk Non-Muscle Invasive Bladder Cancer (IR NMIBC)...

Bakersfield, CAPHASE3454 participantsFerring Pharmaceuticals

View Study Details

NCT06567743Recruiting

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

This is a Phase 2, Multi-Arm, Multi-Cohort, Open-Label Study to Evaluate the Safety and Efficacy of Cretostimogene Grenadenorepvec in Participants with High-Risk Non-Muscle-Invasive Bladder Cancer....

Bakersfield, CAPHASE2325 participantsCG Oncology, Inc.

View Study Details

NCT06833073Recruiting

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

Researchers are looking for new ways to treat people with high-risk non-muscle invasive bladder cancer (HR NMIBC). NMIBC is cancer in the tissue that lines the inside of the bladder but has not spread...

Bakersfield, CAPHASE2308 participantsMerck Sharp & Dohme LLC

View Study Details

NCT06992427Recruiting

High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer

This phase III trial tests if gabapentin can prevent the need for opiate pain medication for mouth sores (oral mucositis) in patients undergoing treatment with chemotherapy and radiation for squamous ...

Bakersfield, CAPHASE3228 participantsAlliance for Clinical Trials in Oncology

View Study Details

NCT06770582Recruiting

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

This phase II trial compares the use of pembrolizumab and radiation therapy to chemotherapy with cisplatin, gemcitabine, 5-fluorouracil or mitomycin-C and radiation therapy for the treatment of non-mu...

Bakersfield, CAPHASE2160 participantsNational Cancer Institute (NCI)

View Study Details

NCT05951179Recruiting

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

TARA-002-101-Ph2 is an open-label study to investigate the safety and anti-tumor activity of intravesical instillation of TARA-002 in adults 18 years of age or older with high-grade CIS NMIBC (± Ta/T1...

Bakersfield, CAPHASE2131 participantsProtara Therapeutics

View Study Details

NCT06425926Recruiting

Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors

GIM-531 is a first-in-class, orally bioavailable small molecule that is being developed for the treatment of advanced solid tumors as a single agent and rescue therapy. GIM-531 exhibits its primary ef...

Bakersfield, CAPHASE1117 participantsGeorgiamune Inc

View Study Details

NCT06234098Recruiting

Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, Refractory or Recurrent Solid Tumors

This is a first-in-human, multicenter, open-label, dose escalation and dose expansion Phase 1/2 study to determine the MTD and/or the recommended Phase 2 dose (RP2D) and to characterize DLTs of AT-196...

Bakersfield, CAPHASE185 participantsAlyssum Therapeutics

View Study Details

NCT05710848Recruiting

A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer

This is a first-in-human (FIH), Phase 1/2a, multi center, open-label, single treatment, dose escalation and expansion study designed to determine the safety and tolerability of STM-416 in patients wit...

Bakersfield, CAPHASE175 participantsSURGE Therapeutics

View Study Details

NCT07222488Recruiting

A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)

Researchers are looking for new ways to treat high-risk non-muscle invasive bladder cancer (HR NMIBC). NMIBC is cancer in the tissue that lines the inside of the bladder and has not spread to the blad...

Bakersfield, CAPHASE145 participantsMerck Sharp & Dohme LLC

View Study Details

NCT06637423Recruiting

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)

The goal of the study is to learn about the safety of Sacituzumab Tirumotecan and if people can tolerate it when given in the bladder and find the highest dose that people can take without having cert...

Bakersfield, CAPHASE132 participantsMerck Sharp & Dohme LLC

View Study Details

About Atopic Dermatitis Clinical Trials in Bakersfield

Atopic dermatitis (eczema) is a chronic inflammatory skin condition causing itchy, red, and dry skin. It is the most common form of eczema, often beginning in childhood. Treatment includes moisturizers, topical corticosteroids, immunomodulators, and newer biologics like dupilumab.

There are currently 13 atopic dermatitis clinical trials recruiting participants in Bakersfield, CA. These studies are seeking a combined 6,460 participants. Research is being sponsored by Merck Sharp & Dohme LLC, Sanofi, Ferring Pharmaceuticals and 7 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Atopic Dermatitis Clinical Trials in Bakersfield — FAQ

Are there atopic dermatitis clinical trials in Bakersfield?

Yes, there are 13 atopic dermatitis clinical trials currently recruiting in Bakersfield, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Bakersfield?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Bakersfield research site will contact you about next steps.

Are clinical trials in Bakersfield free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Bakersfield studies also compensate for your time and travel.

What atopic dermatitis treatments are being tested?

The 13 active trials in Bakersfield are testing new therapies including novel drugs, biologics, and treatment approaches for atopic dermatitis.

Data updated July 22, 2026 from ClinicalTrials.gov